Register
Abstract
Exhibitors & Sponsors

Launched in 2010, the Singapore-Stanford Biodesign (SSB) Programme is a joint partnership between the Agency for Science, Technology and Research (A*STAR), the Economic Development Board (EDB) and Stanford University. Modelled after the established Biodesign Programme at Stanford University, this capability development initiative aims to train and nurture the next generation of medical technology innovators for Singapore and Asia. Since 5 December 2019, SSB has been re-named as Singapore Biodesign, signifying a move to being more Asia and implementation focussed to bring about economic benefits and healthcare value through healthtech innovation training.

Singapore Biodesign

Phone: +65 8793 6406